An investigational peptide that activates GLP-1, GIP, and glucagon receptors and is being studied for obesity and metabolic conditions. It is not an FDA-approved medication.
Also called: Reta, LY3437943
An investigational peptide that activates GLP-1, GIP, and glucagon receptors and is being studied for obesity and metabolic conditions. It is not an FDA-approved medication.
Also called: Reta, LY3437943